Abstract
Discovery of new markers for the identification and discrimination of cell types is one of the principal objectives in cancer diagnostics. In the last years, many researchers used phage-display technology in vitro and in vivo to obtain random peptide probes able to bind towards cancer targets to be used in diagnostic systems and new targeted drug. In this work, we proposed a Single Drop Biosensor based on phage-labelled probes to detect leukaemia cells in blood from patients affected by chronic lymphocytic leukaemia (CLL). Results show that phage-labelled probes were able to recognize lymphocytes and lymphoblastic cells both in leukemic peripheral blood mononuclear cells and in whole blood from patients affected by CLL. The “proof of concept” proposed, using the phage labelled as bio-probe, could be an alternative way to produce new biosensor for monitoring of chronic pathology. Furthermore the results may have translational relevance for identification and exploring of new ligands directed against cancer hematological cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Riehemann, K., Schneider, S.W., Luger, T.A., Godin, B., Ferrari, M., Fuchs, H.: Nanomedicine–challenge and perspectives. Angew. Chem. Int. Ed. 48, 872–897 (2009)
Schally, A.V., Comaru-Schally, A.M., Plonowski, A., Nagy, A., Halmos, G., Rekasi, Z.: Peptide analogues in the therapy of prostate cancer. Prostate 45, 158–166 (2000)
Zhao, Y., Ji, T., Wangm, H., Li, S., Zhao, Y., Nie, G.: Self-assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging. J. Control. Release 177, 11–19 (2014)
Sosabowski, J.K., Mather, S.J.: Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat. Protoc. 1(2), 972–976 (2006)
Yang, L., Mao, H., Cao, Z., Wang, A., Peng, X., Wang, X., Karna, P., Adams, G., Yuan, Q., Staley, C., Wood, W.C., Nie, S., Gao, X.: Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer. NSTI-Nanotechnol. 2, 17–20 (2006)
Flierl, A., Jackson, C., Cottrell, B., Murdock, D., Seibel, P., Wallace, D.C.: Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol. Ther. 7, 50–57 (2003)
Akrami, M., Balalaie, S., Hosseinkhani, S., Alipour, M., Salehi, F., Bahador, A., Haririan, I.: Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms. Sci. Rep. 6, 31030 (2016)
Ghosh, D., Kohli, A.G., Moser, F., Endy, D., Belcher, A.M.: Refactored M13 bacteriophage as a platform for tumor cell imaging and drug deliver. ACS Synth. Biol. 1, 576–582 (2012)
Herman, R.E., Makienko, E.G., Prieve, M.G., Fuller, M., Houston Jr., M.E., Johnson, P.H.: Phage display screening of epithelial cell monolayers treated with EGTA: identification of peptide FDFWITP that modulates tight junction activity. J. Biomol. Screen. 12, 1092–1101 (2007)
Sun, X., Niu, G., Yan, Y., Yang, M., Chen, K., Ma, Y., Chan, N., Shen, B., Chen, X.: Phage display-derived Peptides for osteosarcoma imaging. Clin. Cancer Res. 16, 4268–4277 (2010)
Cao, Q., Liu, S., Niu, G., Chen, K., Yan, Y., Liu, Z., Chen, X.: Phage display peptide probes for imaging early response to bevacizumab treatment. Amino Acids 41, 1103–1111 (2011)
Li, K., Chen, Y., Li, S., Nguyen, H.G., Niu, Z., You, S., Mello, C.M., Lu, X., Wang, Q.: Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjug. Chem. 21, 1369–1376 (2010)
Lentini, G., Fazio, E., Calabrese, F., De Plano, L.M., Puliafico, M., Franco, D., Nicolò, M.S., Carnazza, S., Trusso, S., Allegra, A., Neri, F., Musolino, C., Guglielmino, S.P.P.: Phage-AgNPs complex as SERS probe for U937 cell identification. Biosens. Bioelectron. 74, 398–405 (2015)
Smith, S., Giriat, I., Schmitt, A., de Lange, T.: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484–1487 (1998)
Chi, N.W., Lodish, H.F.: Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J. Biol. Chem. 275, 38437–38444 (2000)
Bae, J., Donigian, J.R., Hsueh, A.J.: Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis. J. Biol. Chem. 278, 5195–5204 (2003)
Gao, J., Zhang, J., Long, Y., Tian, Y., Lu, X.: Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity. Pathol. Oncol. Res. 17(3), 685–690 (2011)
Chang, W., Dynek, J.N., Smith, S.: NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem. J. 391(Pt 2), 177–184 (2005)
Acknowledgements
This work was supported by Associazione pro Bambini e Adulti Leucemici (A.B.A.L.) onlus Messina (Italy) (http://www.abalmessina.it).
Phage-display libraries were a kind gift of Prof. Franco Felici.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Franco, D. et al. (2019). FITC-Labelled Clone from Phage Display for Direct Detection of Leukemia Cells in Blood. In: Andò, B., et al. Sensors. CNS 2018. Lecture Notes in Electrical Engineering, vol 539. Springer, Cham. https://doi.org/10.1007/978-3-030-04324-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-04324-7_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04323-0
Online ISBN: 978-3-030-04324-7
eBook Packages: EngineeringEngineering (R0)